{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:55:30Z","timestamp":1792061730033,"version":"4.4.0"},"reference-count":117,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T00:00:00Z","timestamp":1776384000000},"content-version":"vor","delay-in-days":959,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chinese Medical Sciences Journal"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.24920\/004203","type":"journal-article","created":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T02:58:28Z","timestamp":1695265108000},"page":"163-177","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Expert Consensus on Acute Respiratory Failure in Critically III Cancer Patients (2023)"],"prefix":"10.1016","volume":"38","author":[{"given":"Hai-Jun","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Zhi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"He-Ling","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Zhong","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.24920\/004203_bib1","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1164\/rccm.202009-3467OC","article-title":"Ventilatory variables and mechanical power in patients with acute respiratory distress syndrome","volume":"204","author":"Costa","year":"2021","journal-title":"Am J Respir Crlt Care Med"},{"issue":"1","key":"10.24920\/004203_bib2","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13613-021-00968-5","article-title":"Patterns of ICU admissions and outcomes in patients with solid malignancies over the revolution of cancer treatment","volume":"11","author":"Vigneron","year":"2021","journal-title":"Ann Intensive Care"},{"issue":"1","key":"10.24920\/004203_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/ACO.0000000000000945","article-title":"Minimizing postoperative pulmonary complications in thoracic surgery patients","volume":"34","author":"Kaufmann","year":"2021","journal-title":"Curr Opin Anaesthesiol"},{"issue":"1","key":"10.24920\/004203_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1097\/CCM.0000000000004087","article-title":"Critical care management of toxicities associated with targeted agents and immunotherapies for cancer","volume":"48","author":"Gutierrez","year":"2020","journal-title":"Crit Care Med"},{"issue":"3","key":"10.24920\/004203_bib5","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1007\/s00134-022-06635-y","article-title":"Veno-venous extracorporeal membrane oxygenation (vv-ECMO) for severe respiratory failure in adult cancer patients: a retrospective multicenter analysis","volume":"48","author":"Kochanek","year":"2022","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.24920\/004203_bib6","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4212\/cjhp.v73i4.3027","article-title":"Chemotherapy in the intensive care unit: an evaluation of context and outcomes","volume":"73","author":"Kanji","year":"2020","journal-title":"Can J Hosp Pharm"},{"issue":"10","key":"10.24920\/004203_bib7","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1007\/s00134-021-06508-w","article-title":"Critically ill cancer patients consensus conference group. Critically ill cancer patient\u2019s resuscitation: a Belgian\/French societies\u2019 consensus conference","volume":"47","author":"Meert","year":"2021","journal-title":"Intensive Care Med"},{"issue":"14","key":"10.24920\/004203_bib8","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1002\/cncr.31409","article-title":"Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit","volume":"124","author":"Pastores","year":"2018","journal-title":"Cancer"},{"issue":"2","key":"10.24920\/004203_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s00134-020-06184-2","article-title":"Trends in clinical profiles, organ support use and outcomes of patients with cancer requiring unplanned ICU admission: a multicenter cohort study","volume":"47","author":"Zampieri","year":"2021","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.24920\/004203_bib10","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/08850666211054369","article-title":"One-year mortality of cancer patients with an unplanned ICU admission: a cohort analysis between 2008 and 2017 in the Netherlands","volume":"37","author":"van der Zee","year":"2022","journal-title":"J Intensive Care Med"},{"issue":"7650","key":"10.24920\/004203_bib11","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE Working Group. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"suppl_2","key":"10.24920\/004203_bib12","doi-asserted-by":"crossref","first-page":"S231","DOI":"10.1093\/cid\/ciy693","article-title":"Microbiological Diagnostic Performance of Metagenomic Next-generation Sequencing When Applied to Clinical Practice","volume":"67","author":"Miao","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.24920\/004203_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2022.100404","article-title":"Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment","volume":"7","author":"Conte","year":"2022","journal-title":"ESMO Open"},{"issue":"1","key":"10.24920\/004203_bib14","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/s12890-019-1022-4","article-title":"Metagenomic next-generation sequencing for mixed pulmonary infection diagnosis","volume":"19","author":"Wang","year":"2019","journal-title":"BMC Pulm Med"},{"issue":"9","key":"10.24920\/004203_bib15","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.21037\/jtd-20-930","article-title":"Comparison of the next-generation sequencing (NGS) technology with culture methods in the diagnosis of bacterial and fungal infections","volume":"12","author":"Chen","year":"2020","journal-title":"J Thorac Dis"},{"issue":"10","key":"10.24920\/004203_bib16","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1016\/j.jmoldx.2021.06.007","article-title":"Clinical impact of metagenomic next-generation sequencing of bronchoalveolar lavage in the diagnosis and management of pneumonia: a multicenter prospective observational study","volume":"23","author":"Zhou","year":"2021","journal-title":"J Mol Diagn"},{"issue":"3","key":"10.24920\/004203_bib17","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s40121-021-00476-w","article-title":"Exploring the clinical utility of metagenomic next-generation sequencing in the diagnosis of pulmonary infection","volume":"10","author":"Xie","year":"2021","journal-title":"Infect Dis Ther"},{"key":"10.24920\/004203_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2021.661589","article-title":"Metagenomic next-generation sequencing for pathogenic diagnosis and antibiotic management of severe community-acquired pneumonia in immunocompromised adults","volume":"11","author":"Sun","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"issue":"1","key":"10.24920\/004203_bib19","doi-asserted-by":"crossref","DOI":"10.1099\/jmm.0.001259","article-title":"The clinical significance of simultaneous detection of pathogens from bronchoalveolar lavage fluid and blood samples by metagenomic next-generation sequencing in patients with severe pneumonia","volume":"70","author":"Chen","year":"2021","journal-title":"J Med Microbiol"},{"issue":"2","key":"10.24920\/004203_bib20","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3892\/br.2021.1497","article-title":"Next-generation sequencing as an advanced supplementary tool for the diagnosis of pathogens in lower respiratory tract infections: An observational trial in Xi\u2019an, China","volume":"16","author":"Shao","year":"2022","journal-title":"Biomed Rep"},{"issue":"5","key":"10.24920\/004203_bib21","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1378\/chest.07-2134","article-title":"Mortality rates for patients with acute lung injury\/ARDS have decreased over time","volume":"13","author":"Zambon","year":"2008","journal-title":"Chest"},{"issue":"8","key":"10.24920\/004203_bib22","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2016.0291","article-title":"LUNG SAFE investigators; ESICM trials group. Epidemiology, patterns of care, and mortality for patients with acute respiratory distress syndrome in intensive care units in 50 countries","volume":"315","author":"Bellani","year":"2016","journal-title":"JAMA"},{"issue":"12","key":"10.24920\/004203_bib23","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1007\/s00134-017-4947-1","article-title":"Efraim investigators and the Nine-I study group. Acute hypoxemic respiratory failure in immunocompromised patients: the Efraim multinational prospective cohort study","volume":"43","author":"Azoulay","year":"2017","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.24920\/004203_bib24","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1215716","article-title":"OSCAR Study Group. High-frequency oscillation for acute respiratory distress syndrome","volume":"368","author":"Young","year":"2013","journal-title":"N Engl J Med"},{"issue":"9","key":"10.24920\/004203_bib25","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1215554","article-title":"OSCILLATE Trial Investigators; Canadian Critical Care Trials Group. High-frequency oscillation in early acute respiratory distress syndrome","volume":"368","author":"Ferguson","year":"2013","journal-title":"N Engl J Med"},{"issue":"23","key":"10.24920\/004203_bib26","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1056\/NEJMoa1214103","article-title":"PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome","volume":"368","author":"Gu\u00e9rin","year":"2013","journal-title":"N Engl J Med"},{"issue":"18","key":"10.24920\/004203_bib27","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1403285","article-title":"HARP-2 Investigators; Irish Critical Care Trials Group. Simvastatin in the acute respiratory distress syndrome","volume":"371","author":"McAuley","year":"2014","journal-title":"N Engl J Med"},{"issue":"1","key":"10.24920\/004203_bib28","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1097\/CCM.0000000000001383","article-title":"Open Lung Approach Network. Open lung approach for the acute respiratory distress syndrome: a pilot, randomized controlled trial","volume":"44","author":"Kacmarek","year":"2016","journal-title":"Crit Care Med"},{"issue":"14","key":"10.24920\/004203_bib29","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jama.2017.14171","article-title":"Effect of lung recruitment and titrated positive end-expiratory pressure (PEEP) vs low peep on mortality in patients with acute respiratory distress syndrome: a randomized clinical trial","volume":"318","author":"Writing Group for the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial (ART) Investigators","year":"2017","journal-title":"JAMA"},{"issue":"21","key":"10.24920\/004203_bib30","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1056\/NEJMoa1901686","article-title":"National Heart, Lung, and Blood Institute PETAL Clinical Trials Network. Early neuromuscular blockade in the acute respiratory distress syndrome","volume":"380","author":"Moss","year":"2019","journal-title":"N Engl J Med"},{"issue":"9","key":"10.24920\/004203_bib31","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1001\/jama.2019.0555","volume":"321","author":"Beitier","year":"2019","journal-title":"JAMA"},{"issue":"11","key":"10.24920\/004203_bib32","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1164\/rccm.201901-0109OC","article-title":"Maximal recruitment open lung ventilation in acute respiratory distress syndrome (PHARLAP). A phase II, multicenter randomized controlled clinical trial","volume":"200","author":"Hodgson","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"10.24920\/004203_bib33","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-2600(19)30417-5","article-title":"dexamethasone in ARDS network. Dexamethasone treatment for the acute respiratory distress syndrome: a multicentre, randomised controlled trial","volume":"8","author":"Villar","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"8","key":"10.24920\/004203_bib34","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1001\/jama.2019.22525","article-title":"INTEREST Study Group. Effect of intravenous interferon \u03b2-1a on death and days free from mechanical ventilation among patients with moderate to severe acute respiratory distress syndrome: a randomized clinical trial","volume":"323","author":"Ranieri","year":"2020","journal-title":"JAMA"},{"issue":"3","key":"10.24920\/004203_bib35","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1179\/1607845412Y.0000000038","article-title":"Acute respiratory distress syndrome in patients with hematological malignancies","volume":"18","author":"T\u00fcrkoglu","year":"2013","journal-title":"Hematology"},{"issue":"8","key":"10.24920\/004203_bib36","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1007\/s00134-014-3354-0","article-title":"Acute respiratory distress syndrome in patients with malignancies","volume":"40","author":"Azoulay","year":"2014","journal-title":"Intensive Care Med"},{"issue":"9","key":"10.24920\/004203_bib37","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/anae.13542","article-title":"Severity of Acute Respiratory Distress Syndrome in haematology patients: long-term impact and early predictive factors","volume":"71","author":"Lagier","year":"2016","journal-title":"Anaesthesia"},{"issue":"4","key":"10.24920\/004203_bib38","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1016\/j.jtcvs.2018.06.021","article-title":"Early acute respiratory distress syndrome after pneumonectomy: Presentation, management, and short- and long-term outcomes","volume":"156","author":"Blanc","year":"2018","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.24920\/004203_bib39","article-title":"Clinical characteristics and outcomes of acute lung injury caused by transcatheter arterial chemoembolization for hepatocellular carcinoma: a retrospective cohort study from a single institution in China","volume":"2019","author":"Fang","year":"2019","journal-title":"Anal Cell Pathol (Amst)"},{"key":"10.24920\/004203_bib40","article-title":"Early corticosteroid treatment for postoperative acute lung injury after lung cancer surgery","volume":"13","author":"Choi","year":"2019","journal-title":"Thier Adv Respir Dis"},{"issue":"4","key":"10.24920\/004203_bib41","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1177\/0885066617753566","article-title":"Prognosis of acute respiratory distress syndrome in patients with hematological malignancies","volume":"35","author":"Seong","year":"2020","journal-title":"J Intensive Care Med"},{"issue":"21","key":"10.24920\/004203_bib42","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1056\/NEJMoa1800385","article-title":"EOLIA Trial Group, REVA, and ECMONet. Extracorporeal membrane oxygenation for severe acute respiratory distress syndrome","volume":"378","author":"Combes","year":"2018","journal-title":"N Engl J Med"},{"issue":"5","key":"10.24920\/004203_bib43","doi-asserted-by":"crossref","first-page":"e500","DOI":"10.1097\/CCM.0000000000002293","volume":"45","author":"Wohlfarth","year":"2017","journal-title":"Crit Care Med"},{"issue":"9","key":"10.24920\/004203_bib44","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1159\/000489718","article-title":"Extracorporeal membrane oxygenation in predominantly leuco- and thrombocytopenic haemato-logic\/oncologic patients with acute respiratory distress syndrome: a single-centre experience","volume":"41","author":"Stecher","year":"2018","journal-title":"Oncol Res Treat"},{"issue":"10","key":"10.24920\/004203_bib45","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1164\/rccm.201708-1761OC","article-title":"IDEA Study Group. Six-month outcome of immunocompromised patients with severe acute respiratory distress syndrome rescued by extracorporeal membrane oxygenation. An international multicenter retrospective study","volume":"197","author":"Schmidt","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"issue":"9","key":"10.24920\/004203_bib46","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1111\/aor.13954","article-title":"Influence of immunosuppression in patients with severe acute respiratory distress syndrome on ve-no-venous extracorporeal membrane oxygenation therapy","volume":"45","author":"Rilinger","year":"2021","journal-title":"Artif Organs"},{"key":"10.24920\/004203_bib47","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3389\/fimmu.2019.00108","article-title":"Risk of pneumonitis and pneumonia associated with immune checkpoint inhibitors for solid tumors: a systematic review and meta-analysis","volume":"10","author":"Su","year":"2019","journal-title":"Front Immunol"},{"key":"10.24920\/004203_bib48","author":"National Cancer Institute"},{"issue":"5","key":"10.24920\/004203_bib49","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1200\/JCO.2012.44.6112","article-title":"Phase III randomized clinical trial comparing tremelimumab with standard-of-care chemotherapy in patients with advanced melanoma","volume":"31","author":"Ribas","year":"2013","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.24920\/004203_bib50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa1504627","article-title":"Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer","volume":"373","author":"Brahmer","year":"2015","journal-title":"N Engl J Med"},{"issue":"19","key":"10.24920\/004203_bib51","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1056\/NEJMoa1510665","article-title":"CheckMate 025 investigators, nivolumab versus everolimus in advanced renal-cell carcinoma","volume":"373","author":"Motzer","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.24920\/004203_bib52","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S1470-2045(15)70076-8","article-title":"Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial","volume":"16","author":"Weber","year":"2015","journal-title":"Lancet Oncol"},{"issue":"17","key":"10.24920\/004203_bib53","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1056\/NEJMoa1507643","article-title":"Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer","volume":"373","author":"Borghaei","year":"2015","journal-title":"N Engl J Med"},{"issue":"4","key":"10.24920\/004203_bib54","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1056\/NEJMoa1412082","article-title":"Nivolumab in previously untreated melanoma without BRAF mutation","volume":"372","author":"Robert","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"10.24920\/004203_bib55","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/S1470-2045(15)00083-2","article-title":"Pembrolizumab versus investigator-choice chemotherapy for ipilimumab-refractory melanoma (KEY-NOTE-002): a randomised, controlled, phase 2 trial","volume":"16","author":"Ribas","year":"2015","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.24920\/004203_bib56","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa1602252","article-title":"Nivolumab for recurrent squamous-cell carcinoma of the head and neck","volume":"375","author":"Ferris","year":"2016","journal-title":"N Engl J Med"},{"issue":"10027","key":"10.24920\/004203_bib57","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1016\/S0140-6736(15)01281-7","article-title":"Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial","volume":"387","author":"Herbst","year":"2016","journal-title":"Lancet"},{"issue":"19","key":"10.24920\/004203_bib58","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJMoa1606774","article-title":"KEYNOTE-024 Investigators. Pembrolizumab versus Chemotherapy for PD-L1-positive non-small-cell lung cancer","volume":"375","author":"Reck","year":"2016","journal-title":"N Engl J Med"},{"issue":"25","key":"10.24920\/004203_bib59","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1056\/NEJMoa1613493","article-title":"CheckMate 026 Investigators. First-line nivolumab in stage iv or recurrent non-small-cell lung cancer","volume":"376","author":"Carbone","year":"2017","journal-title":"N Engl J Med"},{"issue":"11","key":"10.24920\/004203_bib60","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa1613683","article-title":"KEYNOTE-045 Investigators. Pembrolizumab as second-line therapy for advanced urothelial carcinoma","volume":"376","author":"Bellmunt","year":"2017","journal-title":"N Engl J Med"},{"issue":"22","key":"10.24920\/004203_bib61","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1801946","article-title":"Nivolumab plus Ipilimum-ab in lung cancer with a high tumor mutational burden","volume":"378","author":"Hellmann","year":"2018","journal-title":"N Engl J Med"},{"issue":"11","key":"10.24920\/004203_bib62","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1016\/S1470-2045(18)30673-9","article-title":"Avelumab versus docetaxel in patients with platinum-treated advanced non-small-cell lung cancer (JAVELIN Lung 200): an open-label, randomised, phase 3 study","volume":"19","author":"Barlesi","year":"2018","journal-title":"Lancet Oncol"},{"issue":"10142","key":"10.24920\/004203_bib63","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(18)31257-1","article-title":"KEYNOTE-061 Investigators. Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial","volume":"392","author":"Shitara","year":"2018","journal-title":"Lancet"},{"issue":"11","key":"10.24920\/004203_bib64","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1016\/S1470-2045(19)30626-6","article-title":"Nivolumab versus chemotherapy in patients with advanced oesophageal squamous cell carcinoma refractory or intolerant to previous chemotherapy (ATTRACTI0N-3): a multicentre, randomised, open-label, phase 3 trial","volume":"20","author":"Kato","year":"2019","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.24920\/004203_bib65","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.jtho.2019.01.006","article-title":"Nivolumab versus docetaxel in a predominantly Chinese patient population with previously treated advanced NS-CLC: CheckMate 078 randomized phase III clinical trial","volume":"14","author":"Wu","year":"2019","journal-title":"J Thorac Oncol"},{"issue":"10167","key":"10.24920\/004203_bib66","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(18)31999-8","article-title":"KEYNOTE-040 Investigators. Pembrolizumab versus methotrexate, docetaxel, or cetuximab for recurrent or metastatic head-and-neck squamous cell carcinoma (KEY-NOTE-040): a randomised, open-label, phase 3 study","volume":"393","author":"Cohen","year":"2019","journal-title":"Lancet"},{"issue":"10183","key":"10.24920\/004203_bib67","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1016\/S0140-6736(18)32409-7","article-title":"KEYNOTE-042 Investigators. Pembrolizumab versus chemotherapy for previously untreated, PD-L1-expressing, locally advanced or metastatic non-small-cell lung cancer (KEY-NOTE-042): a randomised, open-label, controlled, phase 3 trial","volume":"393","author":"Mok","year":"2019","journal-title":"Lancet"},{"issue":"12","key":"10.24920\/004203_bib68","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/S1470-2045(20)30541-6","volume":"21","author":"Powles","year":"2020","journal-title":"Lancet Oncol"},{"issue":"10","key":"10.24920\/004203_bib69","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1001\/jamaoncol.2020.3370","article-title":"Efficacy and safety of pembrolizumab or pembrolizumab plus chemotherapy vs chemotherapy alone for patients with first-line, advanced gastric cancer: the KEYNOTE-062 Phase 3 randomized clinical trial","volume":"6","author":"Shitara","year":"2020","journal-title":"JAMA Oncol"},{"issue":"5","key":"10.24920\/004203_bib70","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1001\/jamaoncol.2020.0237","article-title":"MYSTIC Investigators. Durvalumab with or without tremelimumab vs standard chemotherapy in first-line treatment of metastatic non-small cell lung cancer: The MYSTIC Phase 3 randomized clinical trial","volume":"6","author":"Rizvi","year":"2020","journal-title":"JAMA Oncol"},{"issue":"2","key":"10.24920\/004203_bib71","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.chest.2021.02.032","article-title":"Immune checkpoint inhibitor-related pneumonitis in lung cancer: real-world incidence, risk factors, and management practices across six health care centers in north Carolina","volume":"160","author":"Atchley","year":"2021","journal-title":"Chest"},{"issue":"1","key":"10.24920\/004203_bib72","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-001731","article-title":"Steroid-refractory PD-(L)1 pneumonitis: incidence, clinical features, treatment, and outcomes","volume":"9","author":"Balaji","year":"2021","journal-title":"J Immunother Cancer"},{"issue":"6","key":"10.24920\/004203_bib73","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1164\/rccm.201906-1202ST","article-title":"Knowledge gaps and research priorities in immune checkpoint inhibitor-related pneumonitis. An official American thoracic society research statement","volume":"200","author":"Sears","year":"2019","journal-title":"Am J Respir Crlt Care Med"},{"issue":"5","key":"10.24920\/004203_bib74","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1001\/jamaoto.2021.0025","article-title":"Association of early vs late tracheostomy placement with pneumonia and ventilator days In critically ill patients: a meta-analysis","volume":"147","author":"Chorath","year":"2021","journal-title":"JAMA Otolaryngol Head Neck Surg"},{"issue":"3","key":"10.24920\/004203_bib75","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000024329","article-title":"Early versus late tracheotomy in ICU patients: a meta-analysis of randomized controlled trials","volume":"100","author":"Deng","year":"2021","journal-title":"Medicine (Baltimore)"},{"issue":"6","key":"10.24920\/004203_bib76","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1097\/00004630-200211000-00009","article-title":"Early tracheostomy does not improve outcome in burn patients","volume":"23","author":"Saffle","year":"2002","journal-title":"J Burn Care Rehabil"},{"issue":"8","key":"10.24920\/004203_bib77","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1097\/01.CCM.0000134835.05161.B6","article-title":"A prospective, randomized, study comparing early percutaneous dilational tracheotomy to prolonged translaryngeal intubation (delayed tracheotomy) in critically ill medical patients","volume":"32","author":"Rumbak","year":"2004","journal-title":"Crlt Care Med"},{"issue":"2","key":"10.24920\/004203_bib78","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1097\/01.TA.0000087646.68382.9A","article-title":"Early tracheostomy versus prolonged endotracheal intubation in severe head injury","volume":"57","author":"Bouderka","year":"2004","journal-title":"J Trauma"},{"issue":"1","key":"10.24920\/004203_bib79","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/01.ta.0000196743.37261.3f","article-title":"Tracheostomy in ventilator dependent trauma patients: a prospective, randomized intention-to-treat study","volume":"60","author":"Barquist","year":"2006","journal-title":"J Trauma"},{"issue":"10","key":"10.24920\/004203_bib80","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00134-008-1195-4","article-title":"Early tracheotomy versus prolonged endotracheal intubation in unselected severely ill ICU patients","volume":"34","author":"Blot","year":"2008","journal-title":"Intensive Care Med"},{"issue":"15","key":"10.24920\/004203_bib81","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1001\/jama.2010.447","article-title":"Early vs late tracheotomy for prevention of pneumonia in mechanically ventilated adult ICU patients: a randomized controlled trial","volume":"303","author":"Terragni","year":"2010","journal-title":"JAMA"},{"issue":"6","key":"10.24920\/004203_bib82","doi-asserted-by":"crossref","first-page":"373","DOI":"10.7326\/0003-4819-154-6-201103150-00002","article-title":"Early percutaneous tracheotomy versus prolonged intubation of mechanically ventilated patients after cardiac surgery: a randomized trial","volume":"154","author":"Trouillet","year":"2011","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.24920\/004203_bib83","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1007\/s00423-011-0873-9","article-title":"Early tracheostomy decreases ventilation time but has no impact on mortality of intensive care patients: a randomized study","volume":"397","author":"Koch","year":"2012","journal-title":"Langenbecks Arch Surg"},{"issue":"11","key":"10.24920\/004203_bib84","first-page":"1925","article-title":"Early versus late percutaneous dilational tracheostomy in critically ill patients anticipated requiring prolonged mechanical ventilation","volume":"125","author":"Zheng","year":"2012","journal-title":"Chin Med J (Engl)"},{"issue":"20","key":"10.24920\/004203_bib85","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1001\/jama.2013.5154","article-title":"Effect of early vs late tracheostomy placement on survival in patients receiving mechanical ventilation: the TracMan randomized trial","volume":"309","author":"Young","year":"2013","journal-title":"JAMA"},{"issue":"1","key":"10.24920\/004203_bib86","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1161\/STROKEAHA.112.669895","article-title":"Stroke-related early tracheostomy versus prolonged orotracheal intubation in neurocritical care trial (SETPOINT): a randomized pilot trial","volume":"44","author":"B\u00f6sel","year":"2013","journal-title":"Stroke"},{"issue":"5","key":"10.24920\/004203_bib87","first-page":"585","article-title":"A randomized clinical trial for the timing of tracheotomy in critically ill patients: factors precluding inclusion In a single center study","volume":"18","author":"Diaz-Prieto","year":"2014","journal-title":"Crlt Care"},{"issue":"1","key":"10.24920\/004203_bib88","first-page":"14","article-title":"Early tracheostomy in severe traumatic brain injury: evidence for decreased mechanical ventilation and increased hospital mortality","volume":"4","author":"Dunham","year":"2014","journal-title":"Int J Burns Trauma"},{"issue":"1","key":"10.24920\/004203_bib89","doi-asserted-by":"crossref","first-page":"75","DOI":"10.22514\/SV141.052018.13","article-title":"The impact of early percutaneous tracheotomy on reduction of the incidence of ventilator associated pneumonia andthe course and outcome of ICU patients","volume":"14","author":"Karlov\u00edc","year":"2018","journal-title":"Signa Vitae"},{"issue":"4","key":"10.24920\/004203_bib90","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01574-2021","article-title":"ERS clinical practice guidelines: high-flow nasal cannula in acute respiratory failure","volume":"59","author":"Oczkowski","year":"2022","journal-title":"Eur Respir J"},{"issue":"7","key":"10.24920\/004203_bib91","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200102153440703","article-title":"Noninvasive ventilation in im-munosuppressed patients with pulmonary infiltrates, fever, and acute respiratory failure","volume":"44","author":"Hilbert","year":"2001","journal-title":"N Engl J Med"},{"issue":"16","key":"10.24920\/004203_bib92","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.2015.12402","article-title":"Groupe de Recherche en R\u00e9animation Respiratoire du patient d\u2019Onco-H\u00e9matologie (GRRR-OH). Effect of noninvasive ventilation vs oxygen therapy on mortality among immunocompromised patients with acute respiratory failure: a randomized clinical trial","volume":"14","author":"Lemiale","year":"2015","journal-title":"JAMA"},{"key":"10.24920\/004203_bib93","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1186\/s13054-015-1097-0","article-title":"The effects of a 2-h trial of high-flow oxygen by nasal cannula versus Venturi mask in immunocompromised patients with hypoxemic acute respiratory failure: a multlcenter randomized trial","volume":"19","author":"Lemiale","year":"2015","journal-title":"Crit Care"},{"issue":"20","key":"10.24920\/004203_bib94","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1001\/jama.2018.14282","article-title":"Effect of high-flow nasal oxygen vs standard oxygen on 28-day mortality in immunocompromised patients with acute respiratory failure: the HIGH randomized clinical trial","volume":"320","author":"Azoulay","year":"2018","journal-title":"JAMA"},{"issue":"11","key":"10.24920\/004203_bib95","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1007\/s00134-015-3994-8","article-title":"High-flow oxygen therapy in cancer patients with acute respiratory failure","volume":"1","author":"Mokart","year":"2015","journal-title":"Intensive Care Med"},{"issue":"8","key":"10.24920\/004203_bib96","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/S2213-2600(16)30093-5","article-title":"REVA network. Effect of non-invasive oxygenation strategies in immunocompromised patients with severe acute respiratory failure: a post-hoc analysis of a randomised trial","volume":"4","author":"Frat","year":"2016","journal-title":"Lancet Respir Med"},{"issue":"12","key":"10.24920\/004203_bib97","article-title":"Outcomes and risk factors of critically ill patients with hematological malignancy. Prospective single-centre observational study","volume":"57","author":"Judickas","year":"2021","journal-title":"Medicina (Kaunas)"},{"issue":"11","key":"10.24920\/004203_bib98","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1097\/01.CCM.0000181728.13354.0A","article-title":"Intensive care in patients with newly diagnosed malignancies and a need for cancer chemotherapy","volume":"33","author":"Darmon","year":"2005","journal-title":"Crlt Care Med"},{"issue":"1","key":"10.24920\/004203_bib99","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s00134-005-2836-5","article-title":"Outcome in severely ill patients with hematological malignancies who received intravenous chemotherapy in the intensive care unit","volume":"32","author":"Benoit","year":"2006","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.24920\/004203_bib100","first-page":"491","article-title":"Risk factors to predict outcome in critically ill cancer patients receiving chemotherapy in the intensive care unit","volume":"19","author":"Song","year":"2011","journal-title":"Support Care Cancer"},{"issue":"10","key":"10.24920\/004203_bib101","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00277-014-2141-x","volume":"93","author":"Wohlfarth","year":"2014","journal-title":"Ann Hematol"},{"issue":"6","key":"10.24920\/004203_bib102","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.cllc.2016.04.004","article-title":"Treatment of lung cancer patients with actionable mutations in the intensive care unit","volume":"17","author":"Kerrigan","year":"2016","journal-title":"Clin Lung Cancer"},{"issue":"7","key":"10.24920\/004203_bib103","doi-asserted-by":"crossref","first-page":"e640","DOI":"10.1097\/CCM.0000000000002331","article-title":"Groupe de Recherche sur la R\u00e9animation Respiratoire en Onco-H\u00e9matologie (GRRR-OH). Urgent chemotherapy for life-threatening complications related to solid neoplasms","volume":"45","author":"Zerbib","year":"2017","journal-title":"Crit Care Med"},{"issue":"1","key":"10.24920\/004203_bib104","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13613-018-0426-2","article-title":"Lung Cancer in Critical Care (LUCCA) Study Investigators. Characteristics and outcome of patients with newly diagnosed advanced or metastatic lung cancer admitted to intensive care units (ICUs)","volume":"8","author":"Barth","year":"2018","journal-title":"Ann Intensive Care"},{"issue":"14","key":"10.24920\/004203_bib105","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1002\/cncr.31409","article-title":"Characteristics and outcomes of patients with hematologic malignancies receiving chemotherapy in the intensive care unit","volume":"124","author":"Pastores","year":"2018","journal-title":"Cancer"},{"issue":"5","key":"10.24920\/004203_bib106","doi-asserted-by":"crossref","first-page":"e465","DOI":"10.1097\/CCM.0000000000002990","article-title":"Urgent chemotherapy In sepsis-like shock related to hematologic malignancies","volume":"46","author":"Cherruault","year":"2018","journal-title":"Crit Care Med"},{"issue":"4","key":"10.24920\/004203_bib107","doi-asserted-by":"crossref","first-page":"279","DOI":"10.4212\/cjhp.v73i4.3027","article-title":"Chemotherapy in the intensive care unit: an evaluation of context and outcomes","volume":"73","author":"Kanji","year":"2020","journal-title":"Can J Hosp Pharm"},{"key":"10.24920\/004203_bib108","article-title":"Chemotherapy for non-small cell lung cancer in the intensive care unit","volume":"26","author":"Nasser","year":"2021","journal-title":"Cancer Treat Res Commun"},{"issue":"10","key":"10.24920\/004203_bib109","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101416","article-title":"Tyrosine kinase inhibitors improved survival of critically ill EGFR-mutant lung cancer patients undergoing mechanical ventilation","volume":"9","author":"Lee","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.24920\/004203_bib110","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.chest.2021.06.079","article-title":"Tyrosine kinase inhibitors for acute respiratory failure because of non-small-cell lung cancer involvement in the ICU","volume":"161","author":"Tandjaoui-Lambiotte","year":"2022","journal-title":"Chest"},{"issue":"6","key":"10.24920\/004203_bib111","first-page":"559","article-title":"Urgent chemotherapy in hematological patients In the ICU","volume":"21","author":"Moors","year":"2015","journal-title":"Curr Opln Crit Care"},{"issue":"12","key":"10.24920\/004203_bib112","first-page":"5862","article-title":"The value of microbiology rapid on-site evaluation of sepsis caused by pulmonary infection","volume":"27","author":"Yan","year":"2023","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"7","key":"10.24920\/004203_bib113","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1007\/s00134-023-07050-7","article-title":"European Society of Intensive Care Medicine Taskforce on ARDS. ESICM guidelines on acute respiratory distress syndrome: definition, phenotyping and respiratory support strategies","volume":"49","author":"Grasselli","year":"2023","journal-title":"Intensive Care Med"},{"issue":"16","key":"10.24920\/004203_bib114","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.2217\/fon-2022-1274","article-title":"Pneumonitis with combined immune checkpoint inhibitors and chemoradiotherapy in locally advanced non-small-cell lung cancer: a systematic review and meta-analysis","volume":"19","author":"Yang","year":"2023","journal-title":"Future Oncol"},{"issue":"3","key":"10.24920\/004203_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12070-022-03280-1","article-title":"Utility of early tracheostomy in critically ill Covid-19 patients: a systematic review","volume":"75","author":"Bhasarkar","year":"2023","journal-title":"Indian J Otolaryngol Head Neck Surg"},{"issue":"1","key":"10.24920\/004203_bib116","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40560-023-00658-3","article-title":"Guideline-based management of acute respiratory failure and acute respiratory distress syndrome","volume":"11","author":"Fujishima","year":"2023","journal-title":"J Intensive Care"},{"key":"10.24920\/004203_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcrc.2023.154399","article-title":"Outcome and factors associated with mortality in patients receiving urgent chemotherapy in the ICU: a retrospective study","volume":"78","author":"Bernard","year":"2023","journal-title":"J Crit Care"}],"container-title":["Chinese Medical Sciences Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1001929423000354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1001929423000354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/cmsj.cams.cn\/previewFile?fileName=Prognostic%20Prediction%20Value%20and%20Biological%20Functions%20of%20Non-Apoptotic%20Regulated%20Cell%20Death%20Genes%20in%20Lung%20Adenocarcinoma&id=56199614&type=pdf&lang=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T10:35:19Z","timestamp":1792060519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1001929423000354"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":117,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S1001929423000354"],"URL":"https:\/\/doi.org\/10.24920\/004203","relation":{},"ISSN":["1001-9294"],"issn-type":[{"value":"1001-9294","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expert Consensus on Acute Respiratory Failure in Critically III Cancer Patients (2023)","name":"articletitle","label":"Article Title"},{"value":"Chinese Medical Sciences Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.24920\/004203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2023 Chinese Academy Medical Sciences. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}